Market Place
Sourcing Support
Xeris scores FDA approval for rare disease med Recorlev
01 Jan 2022 //
FIERCEPHARMA
Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma
05 Oct 2021 //
BUSINESSWIRE
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris
05 Oct 2021 //
GLOBENEWSWIRE
Strongbridge Announces Court Hearing Date ApproveProposed Acquisition by Xeris
23 Sep 2021 //
GLOBENEWSWIRE
Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma
14 Sep 2021 //
BUSINESSWIRE
Strongbridge Announces Shareholder Approval of Proposed Acquisition by Xeris
08 Sep 2021 //
GLOBENEWSWIRE
Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results
05 Aug 2021 //
GLOBENEWSWIRE
Strongbridge Biopharma plc Announces Commencement of Mailing of Proxy Statement
02 Aug 2021 //
GLOBENEWSWIRE
Strongbridge to Report Second Quarter 2021 Financial Results on August 5, 2021
29 Jul 2021 //
GLOBENEWSWIRE
Strongbridge Biopharma Irish Takeover Rules for Relevant Securities in Issue
29 Jul 2021 //
GLOBENEWSWIRE
Strongbridge Special Meeting Connection with the Proposed Acquisition by Xeris
26 Jul 2021 //
GLOBENEWSWIRE
Strongbridge Biopharma plc Announces Data for KEVEYIS
13 Jul 2021 //
GLOBENEWSWIRE
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV
03 Jun 2021 //
GLOBENEWSWIRE
Strongbridge Announces U.S. Food & Drug Administration (FDA) Filing (NDA)
13 May 2021 //
GLOBENEWSWIRE
Strongbridge Biopharma plc Announces Publication of Diabetes Subgroup Analysis
08 Apr 2021 //
GLOBENEWSWIRE
Strongbridge Presents Detailed Results from Pivotal Phase 3 LOGICS Study
22 Mar 2021 //
DDYTOMIC ENHAP
STRONGBRIDGE BIOPHARMA PLC ANNOUNCES PRELIMINARY Q4 AND FULL-YEAR
06 Jan 2021 //
CMLVIZ
Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results
29 Oct 2020 //
GLOBENEWSWIRE
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
16 Sep 2020 //
GLOBENEWSWIRE
Strongbridge Biopharma plc Provides Corporate Update
08 Sep 2020 //
GLOBENEWS WIRE
Strongbridge Biopharma plc Announces Last Patient Completes Last Study V
01 Jul 2020 //
GLOBENEWSWIRE
Strongbridge Biopharma plc Announces $30 M Debt Facility with Avenue Venture
20 May 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.